Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings
Watch Certara’s webinar with Kristin Follman to discover how TFL Studio streamlines the process to…
Certara2025 年 9 月 22 日
Best Practices in Clinical Pharmacology Gap Analysis
2025 年 9 月 19 日 Submitting your New Drug Application (NDA) to the FDA is the ultimate…
Certara2025 年 9 月 19 日
Top 10 Things to Know About ADNCA for Non-Compartmental Analysis
Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…
Certara2025 年 9 月 11 日
Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH)
Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…
Certara2025 年 8 月 29 日
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma
Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…
Certara2025 年 8 月 13 日
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial
Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…
Certara2025 年 8 月 13 日
Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development
Learn how our experts use concentration-QTc (C-QTc) analysis to replace costly TQT studies, streamline QT…
Certara2025 年 8 月 6 日
